Biologics News

LAS VEGAS — As the business of biologic products has continued to grow, scrutiny from the FDA and other federal authorities on the use and promotion of biologics has also increased, according to a speaker.

University of Colorado Medicine has announced the launch of the CU Medicine Regenerative Medicine, Hand and Spine Center, according to a press release.

Scripps Health has announced a $2.7 million grant from the California Institute for Regenerative Medicine to research pluripotent stem cells for the treatment of rotator cuff injuries, according to a press release.

Results published in the Journal of Shoulder and Elbow Surgery showed corticosteroid injections have better short-term efficacy, while platelet-rich plasma injections have better long-term efficacy for patients with rotator cuff injuries.

According to published results, intra-articular corticosteroid injection for manipulation under anesthesia during total knee arthroplasty improved range of motion without increasing risk of joint infection.

Current data do support the potential for PRP to improve the outcomes of rotator cuff repair.

As advancements in musculoskeletal biologic therapies have grown in the past decade, so has clinical use of these therapies despite insufficient evidence for widespread clinical application.

DiscGenics Inc. has received FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy for the treatment of patients with symptomatic lumbar degenerative disc disease, according to a press release.

Result showed intra-articular corticosteroid shoulder injections within 4 weeks of reverse shoulder arthroplasty are associated with increased risks of periprosthetic joint infection at 90-days and 1-year postoperatively.

J. Richard Steadman, MD, founder and chair emeritus of The Steadman Clinic and founder and co-chair of the Steadman Philippon Research Institute, died on Jan. 20.